Supplemental Figure 1 from PPARα Agonist Fenofibrate Enhances Cancer Vaccine Efficacy

The cartoon describes the experimental set-up used to generate the results shown in Figure 1. Groups of mice were injected with B16BrafV600E cells. Starting 6 or 8 days later mice were treated daily for 3 weeks with fenofibrate (FF) or diluent. Tumor sizes were recorded over time.